Newly Approved Drug Therapies (583): Rapamune, Wyeth-Ayerst Laboratories

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Rapamune

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Wyeth-Ayerst Laboratories
Approval Status: Approved September 1999
Treatment for: To prevent organ rejection in patients receiving renal transplants

General Information

An oral solution of sirolimus to act as a prophylaxis to prevent organ rejection in patients that are receiving liver transplants.

Mechanism of Action

Oral solution of sirolimus, 1 mg/ml.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]